Spread the love“`html In an age where technology is advancing at breakneck speed, understanding the impact of modern ...

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...

To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.

Administration has repeatedly irked presumed allies on COVID vaccine policy, from its silence on reported 32 million ...

There's an unexpected factor that can make July and August feel even hotter and more humid: corn. FOX Chicago's Kasey Chronis ...

A comprehensive review by UBC reveals that mRNA vaccines, after billions of doses, remain safe and effective against diseases ...

The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...

Melatonin reduced infection-related inflammation in human fetal membranes in an ex vivo model. The study suggests that this ...

Stocks ended the shortened trading week digesting a weaker-than-expected June jobs report, but the overall market tone stayed ...

Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune disease prospect, ...

During its research day, the firm discussed a cell therapy effort in lupus, dubbed "007," and an AI platform for gleaning ...

Jeff Coller, a pioneering RNA biologist, has spent the past year vehemently advocating for the lifesaving promise of research ...